Weng, Jonathan, Anderson Huang, Tamiru B. Berake, Sarah L. Chen, Brian M. Yan, and Raffi Karagozian. “Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease”. Gastroenterology Research 19, no. 3 (January 1, 2026): 147–154. Accessed June 16, 2026. https://gr.elmerpub.com/index.php/gr/article/view/2136.